Distribution of 13-Valent Pneumococcal Conjugate Vaccine Streptococcus pneumoniae Serotypes in US Adults Aged >=50 Years With Community-Acquired Pneumonia

Validation of an Immunodiagnostic Assay for Detection of 13 Streptococcus pneumoniae Serotype-Specific Polysaccharides in Human Urine

(2012) Michael W. Pride et al.   Clinical and Vaccine Immunology

Effectiveness and Serotype Coverage: Key Criteria for Pneumococcal Vaccines for Adults

(2012) J. D. Grabenstein   CLINICAL INFECTIOUS DISEASES

Pneumococcal Polysaccharide Vaccine Efficacy and Routine Use of Conjugate Vaccines in Infants: There Is No Need for a Vaccine Program in Older Adults at Present

(2012) J. Truck et al.   CLINICAL INFECTIOUS DISEASES

Editorial Commentary: Should 13-Valent Protein-Conjugate Pneumococcal Vaccine Be Used Routinely in Adults?

(2012) D. M. Musher   CLINICAL INFECTIOUS DISEASES

Pneumococcal Conjugate Vaccine for Adults: A New Paradigm

(2012) P. R. Paradiso   CLINICAL INFECTIOUS DISEASES

Cost-effectiveness of Adult Vaccination Strategies Using Pneumococcal Conjugate Vaccine Compared With Pneumococcal Polysaccharide Vaccine

(2012) Kenneth J. Smith et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Association of Diagnostic Coding With Trends in Hospitalizations and Mortality of Patients With Pneumonia, 2003-2009

(2012) Peter K. Lindenauer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumonia

(2012) Thomas Bewick et al.   THORAX

Epidemiology, Antibiotic Therapy, and Clinical Outcomes in Health Care-Associated Pneumonia: A UK Cohort Study

(2011) J. D. Chalmers et al.   CLINICAL INFECTIOUS DISEASES

Geographic Variation in Invasive Pneumococcal Disease Following Pneumococcal Conjugate Vaccine Introduction in the United States

(2011) J. B. Rosen et al.   CLINICAL INFECTIOUS DISEASES

Transmission of Streptococcus pneumoniae in adults may occur through saliva

(2011) H. LEVINE et al.   EPIDEMIOLOGY AND INFECTION

Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study

(2011) Elizabeth Miller et al.   LANCET INFECTIOUS DISEASES

Healthcare utilization and cost of pneumococcal disease in the United States

(2011) Susan S. Huang et al.   VACCINE

Integrated Analysis of FOCUS 1 and FOCUS 2: Randomized, Doubled‐Blinded, Multicenter Phase 3 Trials of the Efficacy and Safety of Ceftaroline Fosamil versus Ceftriaxone in Patients with Community‐Acquired Pneumonia

(2010) Thomas M. File et al.   CLINICAL INFECTIOUS DISEASES

Burden of Community-Acquired Pneumonia in North American Adults

(2010) Thomas M. File et al.   POSTGRADUATE MEDICINE

Clinical and economic burden of pneumococcal disease in older US adults

(2010) Derek Weycker et al.   VACCINE

Efficacy of pneumococcal vaccination in adults: a meta-analysis

(2009) A. Huss et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Severity of Pneumococcal Pneumonia Associated With Genomic Bacterial Load

(2009) Jordi Rello et al.   CHEST

Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine

(2009) Tamara Pilishvili et al.   JOURNAL OF INFECTIOUS DISEASES

Long-Term Morbidity and Mortality After Hospitalization With Community-Acquired Pneumonia

(2008) Jennie Johnstone et al.   MEDICINE

A Comparative Study of Community-Acquired Pneumonia Patients Admitted to the Ward and the ICU

(2007) Marcos I. Restrepo et al.   CHEST